# A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

> **NCT06719479** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **SUNHO（China）BioPharmaceutical CO., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- NPC
- HNSCC
- Recurrence
- Metastasis

## Interventions

- **BIOLOGICAL:** IAE0972+ Methotrexate
- **BIOLOGICAL:** IAE0972+Docetaxel
- **BIOLOGICAL:** IAE0972+Gemcitabine
- **BIOLOGICAL:** IAE0972+Taxanes
- **BIOLOGICAL:** IAE0972+Capecitabine

## Key facts

- **NCT ID:** NCT06719479
- **Lead sponsor:** SUNHO（China）BioPharmaceutical CO., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06719479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06719479, "A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06719479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*